🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Newly Diagnosed Diffuse Large B-cell Lymphoma

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL NCT06151080Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Lenalidomide combined with G-CHOP (LO CHOP) The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk NCT05018520Phase 31 site📍 Shanghai Ruijin Hospital · Tests: Six Courses of R-CHOP Plus Two Courses of Rituximab, Four Courses of R-CHOP Plus Four Courses of Rituximab A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma NCT06683885Phase 1, Phase 21 site📍 Zhengzhou Mingzhi Zhang · Tests: Obutinib or Decitabine, Rituximab, Compound Cyclophosphamide Tablets and Prednisone Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL NCT07749365Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: hypofractionated radiotherapy plus GM-CSF, pomalidomide and glofitamab ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL NCT06693830NA1 site📍 New York Hua-Jay J Cherng, MD · Tests: Phased Variant Enrichment and Detection Sequencing (PhasED-seq), Standard of Care Treatment, De-escalated Treatment Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation NCT07499271Phase 21 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: POLA-R-CHP, Orelabrutinib Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL NCT07494565Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Celecoxib Combined with R-CHOP, R-CHOP Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients NCT06176729Phase 21 site📍 Beijing Yan Zhang, MD · Tests: Polatuzumab Vedotin, Rituximab, Lenalidomide Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes NCT06891157Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Chidamide plus R-CHOP Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission NCT07507318Phase 21 site📍 Shanghai Rong Tao · Tests: Chidamide R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden NCT05040555NA1 site📍 Changchun oubai, MD/PhD · Tests: R-CDOP CHiR Therapy for Elderly DLBCL Intolerant to Chemo NCT06764017Phase 21 site📍 Ningbo First Affiliated Hospital of Ningbo University · Tests: CHiR-DEL The CARDIOPROTECT Trial NCT07654426Phase 21 site📍 Boston Beth Israel Deaconess Medical Center · Tests: Dexrazoxane, Dexrazoxane placebo, Doxorubicin, Liposomal Doxorubicin, Cyclophosphamide HEME-25 Open-Label Feasibility Study of Elranatamab Utilized as Consolidation in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV NCT07647432Phase 11 site📍 Chicago University of Illinois Chicago · Tests: Elranatamab (Elra) AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") NCT07649304Phase 11 site📍 Rockville National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) NCT07680933Phase 21 site📍 Xuzhou The Affiliated Hospital of Xuzhou Medical University · Tests: Orelabrutinib combined with standard immunochemotherapy with or without auto-HSCT Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL NCT07493148Phase 21 site📍 Changchun Ou Bai, MD/PHD · Tests: Chidamide, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy NCT06758037Phase 21 site📍 Ningbo First Affiliated Hospital of Ningbo University · Tests: Drug therapy R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma NCT06594640Phase 1, Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Mitoxantrone Hydrochloride Liposome, Rituximab (R), Cyclophosphamide (CTX), Vincristin, Prednisolone Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial NCT07220187Phase 362 sites📍 Irvine📍 Laguna Hills📍 Orange SWOG Cancer Research Network · Tests: Biospecimen Collection, Computed Tomography, Cyclophosphamide, Doxorubicin Hydrochloride, Echocardiography Test Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression NCT06005870Phase 21 site📍 Wuhan Huazhong University of Science and Technology · Tests: Zanubrutinib plus RCHOP A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma NCT04139304EARLY Phase 19 sites📍 Miami📍 Chicago📍 Baltimore AIDS Malignancy Consortium · Tests: Cyclophosphamide, Daratumumab, Doxorubicin, Doxorubicin Hydrochloride, Etoposide Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma NCT06045247Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Prednisone, Rituximab, Cyclophosphamide, Vincristine, Epcoritamab Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL NCT07072208NA1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Induction therapy-Pro regimen, Consolidation therapy-Pro-pola regimen Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma NCT07371923Phase 21 site📍 Beijing Beijing Tongren Hospital · Tests: Zanubrutinib+Pola-R-CHP
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy